Depo-Provera Mass Tort Case Leads Built for Litigation Success
At Exclusive Leads Agency (ELA), we take a different approach. We deliver Depo-Provera mass tort case leads that are pre-qualified through structured medical-legal screening and AI-assisted intent analysis. Rather than collecting broad inquiries, we identify individuals with confirmed brand-name exposure, documented diagnoses, and the capacity to move forward with representation. Every lead is exclusive to your firm, verified for authenticity, and structured to support conversion into a filed case.
Get Qualified Leads Sent to You
Pay on Cost per Acquisition (CPA)
If you want to Pay on cost per acquisition (CPA) only, the “acquisition” has to be you need a vendor who can tie payment to a real outcome, not vanity metrics like clicks or form fills.
Exclusive Leads Agency supports a performance based acquisition model by pre qualifying Depo Provera claimants through structured medical legal screening, brand name verification, diagnosis confirmation, and documentation integrity checks before delivery.
That means you are not paying for recycled data or “maybe” leads. You are paying for verified, exclusive claimants with the intent and documentation path to convert into representation, with compliance safeguards like TrustedForm or Jornaya and HIPAA aware intake workflows baked in.
You define what counts as an acquisition
- Accepted qualified lead that meets your criteria
- Or a signed retainer that is litigation ready
The vendor does the heavy lifting before you ever see the case
- Brand name exposure verification
- Diagnosis confirmation standards (MRI or CT support)
- Injection timeline documentation (typically one year or four injections)
- Screening for documentation accessibility
You are not paying for junk metrics
- Not clicks
- Not impressions
- Not unverified web forms
- Not recycled leads
Compliance is built in
- TrustedForm or Jornaya certificates for TCPA
- HIPAA aware workflows
- Fraud filtering and identity verification
Choose the CPA deliverable
- Qualified lead package delivered and accepted
- Or executed retainer package with key authorizations included
Require litigation grade pre qualification
- Confirm brand name Depo Provera, not generic medroxyprogesterone acetate
- Confirm meningioma details that match your criteria (grade and location)
Establish timing correlation between use duration and diagnosis date - Score case strength based on documentation trail, causation clarity, and damages potential
Lock in exclusivity
- 100 percent exclusive, never shared or recycled
- Clear replacement standard if a case fails the agreed criteria
Buy Depo Cases on CPA
If you want to buy Depo Cases on CPA, the smartest move is to define “acquisition” as something that actually matters, like an accepted qualified lead package or a signed retainer, then hold the pipeline to that standard. ELA’s Depo Provera qualification process focuses on confirmed brand name exposure, meningioma benchmarks, timing correlation between injections and diagnosis, and early record accessibility checks so your intake team is not stuck chasing twenty year old records blind. The result is simple. Higher conversion, cleaner underwriting of case strength, and a CPA model that aligns incentives so you pay when the case meets your criteria and moves forward.
Here is the clean approach:
Get a case intelligence package, not just contact info
- Completed intake questionnaire
- Consent documentation
- Provider and pharmacy trail for records retrieval
- Optional premium package with signed representation agreement and HIPAA authorizations
Why Depo-Provera Cases Demand Specialized Lead Generation
The legal landscape surrounding birth control injections is evolving rapidly. Securing high-quality Depo-Provera mass tort leads is increasingly difficult due to a crowded marketplace filled with individuals who either do not qualify or never used the brand-name drug.
Since the BMJ study was released, many vendors have prioritized quantity over quality, often sacrificing proper vetting for speed. As a result, firms encounter individuals already signed with other attorneys or those who never received the brand-name medication.
Because many cases date back to the 1990s and early 2000s, they often require decades-old medical records that are difficult to obtain. This places a substantial burden on intake teams.
Our qualification program for Depo-Provera mass tort lawsuit leads is unique and proven. We filter for:
Brand-Name Verification
Many claimants used generic medroxyprogesterone acetate. We focus exclusively on individuals with confirmed brand-name exposure.
Specific Medical Benchmarks
We identify the exact grade and location of the meningioma to ensure alignment with your firm’s criteria.
Timing Correlation
We establish a direct link between duration of use (typically at least one year or four injections) and diagnosis date to strengthen causation arguments.
Recent court decisions regarding medical evidence are accelerating this litigation toward critical hearings scheduled for May 2026. This momentum makes now a strategic time to build your case inventory before filing windows potentially narrow.
Firms securing high-intent Depo-Provera leads today position themselves for stronger leverage at the settlement table tomorrow.
The Medical-Legal Correlation Framework
At ELA, our methodology is built on a structured framework that correlates medical history with legal requirements.
Phase 2 – Documentation Integrity Assessment
We audit record accessibility before delivery. Our team prompts claimants to identify pharmacy locations and healthcare providers and determines whether pathology reports are already available—reducing preliminary investigative burdens on your staff.
Phase 3 – Case Strength Scoring
We evaluate:
- Document Strength: Verifiable prescription trail
- Causation Clarity: Temporal relationship between usage and diagnosis
- Damages Potential: Surgical intervention or permanent neurological deficits
Phase 1 – Legal Threshold Verification
We confirm the claimant meets core filing requirements:
Exposure Verification Protocol
Confirmation of 150 mg intramuscular injection use at least one year prior.
Administration Timeline Documentation
Documentation of injection timelines to ensure administrations align with the relevant liability period associated with Pfizer.
Brand vs. Generic Usage Patterns
Verification of minimum brand-exposure thresholds.
Diagnosis Confirmation Standards
Confirmation of intracranial or spinal meningioma through MRI or CT scan results.
Identity & Compliance Verification
We protect your intake process by filtering fraudulent activity at the source.
Multi-Layer Identity Authentication
- Government-issued identification protocols
- Financial account verification (Plaid integration)
- Fraud pattern detection algorithms
Regulatory Compliance Framework
We maintain 100% TCPA compliance using TrustedForm or Jornaya certificates for every lead. Our processes are HIPAA-compliant and adhere strictly to state marketing laws and attorney ethics standards.
Quality Authenticity Markers
We monitor behavioral indicators, including a claimant’s ability to recall symptoms or provider details. We deliver only prospects genuinely motivated to pursue legal action.
Complete Case Intelligence Packages
Standard Lead Package Includes
- Completed intake questionnaire
- Consent documentation with TrustedForm certificate
- Contact intelligence
Premium Signed Retainer Package Includes
- Executed representation agreement
- HIPAA authorization forms
- Organized initial case file
Flexible Engagement Options
Our models are built to adapt to your internal capacity. You can pick any of the following models according to your firm
Lead Delivery Model
Pre-qualified contacts delivered for your internal intake management. Lower cost per lead and scalable volume.
Signed Retainer Model
We manage the full acquisition process. You receive signed cases ready for case management.
Hybrid Partnership Model
Balanced pipeline of qualified leads and signed retainers to stabilize intake flow.
Custom Criteria Programs
Specify geographic targeting, meningioma grade preferences, or documentation thresholds to align precisely with your litigation strategy.
Investment Structure and Expected Returns
We provide a performance-based pricing framework.
Pricing Framework Overview
The cost of Depo-Provera mass tort case leads depends on criteria such as lead type, documentation depth, and geographic targeting. Because we never resell a claimant, your investment provides access to opportunities your competitors cannot obtain from us.
Performance Metrics We Track
- Lead-to-contact success rates
- Contact-to-consultation conversion percentages
- Consultation-to-signed-retainer rates
- Average case development timelines
- Documentation completeness scores
ROI Calculation Tools
We provide tools to track your return on investment (ROI). For example, if your firm signs 50 cases at a specific acquisition cost, we help project portfolio value based on current MDL settlement tiers and conduct break-even analyses aligned with long-term growth.
Understanding Depo-Provera: From Development to Courtroom
At ELA, we equip partners with litigation intelligence to support strategic case building.
Medical Background for Legal Teams
Depo-Provera is a widely used birth control injection containing medroxyprogesterone acetate. Litigation centers on whether the claimant used the brand-name product, as liability frequently rests with Pfizer rather than generic manufacturers.
The Scientific Evidence Chain
March 2024 BMJ Study
Identified a 5.55-fold increased risk of intracranial meningioma in women using the drug for more than one year.
Supporting Historical Evidence
We have reviewed studies from 1983 and 1991 linking synthetic progestins to tumor growth.
Meningioma Medical-Legal Classification
Grade I – Non-malignant but often requiring invasive surgery; represents high case volume.
Grade II – Atypical tumors with higher recurrence rates and increased settlement value.
Grade III – Malignant and life-threatening; typically command the highest settlement ceilings
Our Approach to Mass Tort Intelligence
Here’s why Exclusive Leads is a trusted partner in mass tort intelligence.
Litigation-First Thinking
Our founders understand the case lifecycle. Every intake question we ask is designed to help your team survive the discovery process.
Technology Without Dependence
We offer seamless API integrations with major case management systems, including Filevine and Litify. You will have a dedicated account manager who understands the Depo Provera litigation and can discuss case quality with you directly.
Ethical Standards as a Competitive Advantage
Our strict adherence to compliance means you receive stronger cases that withstand the scrutiny of defense counsel.
Approved by Trial Attorneys Turned Acquisition Strategists
Our leadership team transitioned from courtroom advocacy to strategic client acquisition. We attend MDL conferences, monitor judicial orders, and continuously refine qualification funnels.
Team Structure
- JD-led quality assurance
- Former plaintiff firm intake professionals
- Compliance officers with legal backgrounds
- Legal technology specialists
- Client success managers with litigation experience
Continuing Legal Education
- Active monitoring of MDL proceedings
- Relationships with plaintiff steering committee members
- Attendance at mass tort litigation conferences
- Consultation with medical expertsbr
- Ongoing review of emerging scientific literature
From First Contact to First Case: Your Partnership Journey
Step 1: Discovery Consultation (Week 1)
We meet to discuss your firm’s specific goals, state availability, and internal intake capacity.
Step 2: Custom Proposal (Week 1-2)
You receive a transparent quote and a sample lead profile. We show you exactly what the data looks like before you commit.
Step 3: Agreement and Onboarding (Week 2-3)
Our tech team integrates our delivery dashboard with your CRM and establishes quality standards.
Step 4: First Leads and Optimization (Week 3+)
We launch your campaign. During the first month, we have weekly check-ins to refine the qualification criteria based on your feedback.
Ready to Build Your Depo Provera Practice?
Contact us now to review availability in your target states and secure exclusive, litigation-ready claimants.
Frequently Asked Questions
We offer 100% exclusivity. Most vendors sell the same lead to three firms; we sell ours once. We also place heavy emphasis on brand-name verification, which is the primary reason these cases fail.
Firms using our pre-screened leads typically achieve a 30% higher conversion rate than those buying generic "web-form" leads because we filter for medical documentation accessibility before delivery.
We stand by our quality. If a lead does not meet the agreed-upon criteria, such as using a generic instead of a brand-name, we provide a replacement lead at no additional cost.
During our discovery call, we will walk you through a sample case file to show the depth of our intake process and the data points we capture.
Our proprietary "Exclusive System” ensures that once a lead is assigned to your firm, it is removed from all other available inventories immediately.
